Maqui Berry.
A Chilean berry whose purple comes from delphinidin anthocyanins. Daily use has been studied around eye comfort and tear film, and it adds anthocyanins to what you already eat.
Reviewed March 2026
- Category
- Berry
What Maqui Berry is, and what it does.
- Does it work
- Suits people on screens all day who want an eye-comfort angle, and anyone eating few fresh fruits. The delphinidin profile is what separates it from an ordinary berry powder.
- How much to take
- Start with 60mg to 162mg a day of standardised extract, which is the daily maintenance band. 300mg is what trials used, a research condition rather than a daily target.
- Time to feel it
- Around four weeks of daily use. Eye comfort work measures out over that stretch, and antioxidant markers move on a blood panel before anything registers as a sensation.
- The first dose
- A quiet day. The pigments are absorbed briefly, conjugated and cleared fast, and most of the dose travels on to the colon. What gets measured turns up weeks later.
- With regular use
- Weeks of daily use show up on tear film comfort measures and on markers of oxidative stress, which is where the delphinidin work has been done.
- How well tolerated
- Well tolerated as a berry extract in the amounts used. Its polyphenols bind non-heme iron in the gut, so space it away from an iron serving. Check with your clinician if you're pregnant.
- How it feels
- Neutral. There's no lift and no drowsiness. What changes is measured on eye comfort and oxidative markers rather than felt.
- The overlooked benefit
- Its purple comes from delphinidin, not the cyanidin colouring most berries. And most of the dose is worked on by gut bacteria in the colon rather than absorbed whole.
60 to 162mg a day is where Maqui Berry works.
Source: Davinelli et al., Panminerva Med 2015 (MaquiBright); Hitoe & Shimoda, J Tradit Complement Med 2017
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Maqui Berry has emerging evidence. Based on 305+ studies.
- tear film and eye comfortRandomised trial
- antioxidant activityIn vitro study
- healthy glucose metabolismRandomised trial
- a healthy inflammatory responseAnimal study
Questions people ask about Maqui Berry.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- People who've already covered the basics (diet, sleep, exercise) and want to fine-tune. It's not essential, but could be worthwhile for the right person.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Maqui is delphinidin dominant and bilberry is a mixed cyanidin and delphinidin source, so together they widen the anthocyanin pool reaching plasma and the colon. Different glycoside patterns are cleaved at different rates, which spreads exposure.
Ascorbate holds anthocyanins and tocopherol in their reduced forms in the aqueous phase, so the flavonoid pool from maqui stays active longer. In a dry blend the two are kept away from moisture, since ascorbate degrades anthocyanin pigment in solution.
Grape seed supplies oligomeric proanthocyanidins while maqui supplies anthocyanins, two flavonoid families with different absorption windows and different microbial metabolites.
Both are handled by intestinal UGT and sulfotransferase enzymes, so a co-dose partly saturates conjugation and leaves more of each aglycone in circulation.
Anthocyanins and the tannins alongside them bind ferric iron in the gut lumen and hold it in an unabsorbable complex. Take the iron dose apart from the berry extract.
Delphinidin glycosides work where water is, tocopherol works inside the lipid bilayer. The two cover different compartments rather than duplicating each other, and water-phase antioxidants participate in regenerating the oxidised tocopheroxyl radical. The chemistry is settled; the clinical size of the pairing is not.
Maqui is used in eye-comfort formulas for its anthocyanins, while lutein is the pigment that actually deposits in macular tissue. They contribute by different routes, which is why they are often formulated together. Confidence stays at Promising because the combination has not been tested as a pair.
Zeaxanthin and lutein are the deposited macular pigments; maqui anthocyanins are circulating polyphenols with short plasma residence. A formula combining them is covering two different mechanisms in eye-comfort support. The pairing itself rests on component evidence, not combination data.
Astaxanthin sits across the lipid bilayer with polar ends in both aqueous faces, while delphinidin glycosides stay in the water phase. Combining them addresses oxidative chemistry in two compartments. This is mechanistic reasoning about antioxidant partitioning, not a measured outcome.
Resveratrol and delphinidin glycosides both come out of grape and berry chemistry and both are studied in the same signalling space. Formulating them together broadens the polyphenol profile of a product. Shared mechanism cuts against assuming their effects simply add up.
Pterostilbene is more lipophilic than the anthocyanins it is paired with, so the two partition differently after absorption. The pairing appears in polyphenol blends on that basis. Evidence for the combination specifically is not there, hence Early.
Both are heavily glucuronidated and sulfated in the gut wall and liver, which is why polyphenol bioavailability is low. Dosing several polyphenols together can put them in competition for the same conjugating enzymes, which is worth naming. The direction of any net change in exposure is not established.
Maqui anthocyanins have been studied for blood sugar markers, and chromium acts on insulin signalling rather than on absorption. Stacking two ingredients that both touch glucose handling can add up more than expected, which matters for anyone already using glucose-lowering medication. Blood glucose here is a marker, not an outcome.
This is an additive effect worth flagging rather than promoting. Berberine acts strongly on glucose handling, and a standardised maqui extract has been studied for the same markers. Combining them may produce a larger fall in glucose markers than either alone, so anyone on glucose-lowering medication needs medical oversight before stacking them.
Gymnema and maqui appear together in glucose-support formulas because both act around sugar entry rather than downstream. The combined effect on fasting glucose markers may exceed either ingredient alone. Additive glycaemic action is a caution as much as a benefit.
Both slow the breakdown of dietary starch and sucrose at the brush border, so less glucose arrives at once. Two inhibitors of the same enzymes may add up, and the shared trade-off is gas and bloating from undigested carbohydrate reaching the colon. In vitro enzyme inhibition is not the same as a measured effect on a meal in people.
Lipoic acid is soluble in both water and lipid, which is what lets it interact with the antioxidant network rather than acting alone. Pairing it with an anthocyanin extract puts a recycler alongside a scavenger. The network chemistry is established; the clinical value of this specific pair is not.
Most swallowed anthocyanin is not absorbed intact. Colonic bacteria cleave the sugar and ring-fission the aglycone into smaller phenolic acids, and those metabolites are much of what circulates. Which bacteria are present therefore changes what a given dose of maqui delivers, which is the mechanistic case for pairing with a probiotic.
Anthocyanin metabolism depends on colonic bacteria, and prebiotic fibre changes which of those bacteria are abundant. Co-formulating fibre with a berry extract is a way to support that conversion. The direction and magnitude of any change in metabolite exposure has not been pinned down for maqui specifically.
Anthocyanins are rapidly glucuronidated, which is why plasma levels are low and short-lived. Piperine slows that conjugation, which is the mechanism behind its use as an absorption adjunct. The same enzyme inhibition affects medicines, so it deserves a caution and not just a benefit line.
The two berries carry different anthocyanidin backbones, cyanidin against delphinidin, which differ in hydroxylation and in stability. Blending them widens the anthocyanin profile of a formula. They share absorption and conjugation routes, so exposure does not simply double.
Anthocyanins degrade with heat, light and oxygen. Mixed tocopherols protect the lipid components of a finished product and are a standard oxidation-control choice. This is stability engineering, not a physiological synergy.
Catechol-type hydroxyls on anthocyanidins can complex divalent minerals before absorption. The effect applies to the meal in which they are taken, not to long-term mineral status in someone eating adequately. Spacing a mineral supplement from a concentrated polyphenol dose avoids the issue.
Nothing specific on file for Maqui Berry. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Maqui Berry actually does.
Maqui's colour comes mostly from delphinidin pigments, which is unusual; most berries lean on cyanidin instead.
The extra hydroxyl groups make delphinidin a strong radical scavenger in the test tube and also make it fragile in heat and light.
Very little anthocyanin gets into the blood unchanged. Most of it is broken down by gut bacteria into smaller compounds, and those are what actually circulate.
Anthocyanins are only their bright colour in acid; at gut and blood pH the molecule shifts into other forms.
Where Maqui Berry comes from.
Maqui berries are picked by hand from wild shrubs in southern Chile, cooled fast, and either freeze-dried whole or soaked to pull the purple pigments out. The pigment liquid is concentrated, dried and tested for how much anthocyanin it actually contains. Freeze-dried whole fruit and a standardised extract are not interchangeable by weight.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Small dark purple berries harvested from wild-growing maqui shrubs in southern Chile and adjacent Argentina, largely by hand from unmanaged stands rather than from plantations.
Fruit is chilled quickly after picking, then destemmed and pressed or pulped. Speed matters because the delphinidin glycosides degrade with warmth and oxygen exposure.
Pigments are drawn out with water or a water and ethanol mixture at controlled low temperature and acidic pH, the conditions that keep anthocyanins in their more stable coloured form.
The extract is passed over an adsorbent resin to concentrate polyphenols and remove sugars and acids, then the solvent is stripped under vacuum at low temperature.
Lots are assayed by spectrophotometry or chromatography and specified on total anthocyanin content, with delphinidin glycosides declared separately in the extracts used clinically.
Dried onto a carrier and encapsulated, or, for whole-fruit products, lyophilised and milled without an extraction step at all.
Getting Maqui Berry from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A delphinidin-rich maqui berry extract lowered fasting and after-meal blood sugar and insulin readings in adults whose glucose sat above the normal range.Randomised trial. Alvarado et al., 2016 (BioMed research international). PMID 28025651 ↗
- An anthocyanin-rich maqui berry extract reduced circulating oxidised LDL and other oxidative stress markers compared with placebo in smokers.Randomised trial. Davinelli et al., 2015 (Journal of the American College of Nutrition). PMID 26400431 ↗
- Maqui berry extract increased measured tear production and self-reported eye comfort scores compared with control over the study period.Randomised trial. Kundu et al., 2023 (Indian journal of ophthalmology). PMID 37026311 ↗
- A short course of a maqui-based formula shifted heart rate variability measures and self-rated psycho-physical resilience in the small group studied.Randomised trial. Cavezzi et al., 2023 (Journal of complementary & integrative medicine). PMID 36420523 ↗
- A standardised maqui berry extract was associated with lower fasting blood glucose and changes in blood lipid measures compared with the control condition in this trial; these are laboratory markers, not clinical outcomes.Randomised trial. Alvarado et al., 2016 (Panminerva Medica). PMID 27820958 ↗
- The authors survey the human supplementation studies of Aristotelia chilensis and conclude the clinical literature is limited in size and heterogeneous in design, with the anthocyanin content the most consistently characterised feature.Narrative review. Arce-Johnson et al., 2026 (Antioxidants). PMID 42351960 ↗
- Maqui supplementation was associated with changes along the gut microbiome and adipose tissue axis together with insulin sensitivity and lipid measures in this preclinical model; these are markers in animals.Animal study. Tume et al., 2026 (Food Chemistry: Molecular Sciences). PMID 41852858 ↗
- A cystatin isolated from maqui berry inhibited cathepsin K activity and was associated with markers of osteogenic differentiation in cultured human dental pulp cells.In vitro study. Silva et al., 2026 (Journal of Applied Oral Science). PMID 41711846 ↗
- The authors review anthocyanin mechanisms relevant to normal kidney function and conclude the supporting work is largely preclinical, with human data still to be generated.Narrative review. Tiscornia et al., 2025 (Nutrients). PMID 40292440 ↗
These are the studies our verdict leans on, chosen from the 148 we read for Maqui Berry. The full linked list is below.
The studies, linked.
5 sources behind our Maqui Berry verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialBeneficial Effects of Maqui Berry Extract Combination With Omega-3 Fatty Acids on Cytokine Reduction in Elderly Obese AdultsClinicalTrials.gov ↗NA · 32 participants · Completed
- Clinical trialA Randomized Controlled Trial to Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain in Overweight But Generally Healthy Adults Over the Winter Holiday PeriodClinicalTrials.gov ↗NA · 23 participants · Completed
- Clinical trialBioavailability of Maqui Berry Extracts (Delphinol® / MaquiBright®) in Healthy SubjectsClinicalTrials.gov ↗12 participants · Completed
- Clinical trialGummy Candies Containing Maqui Berry (Aristotelia Chilensis) to Improve Glycemic Control of Overweight SubjectsClinicalTrials.gov ↗NA · 10 participants · Completed
- Clinical trial"The Effect of Using Preparations With Maqui Berry Extract in Treating Oral Candidiasis in Patients With Diabetes Mellitus and Systemically Healthy Persons"ClinicalTrials.gov ↗PHASE4 · 90 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
